Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8846 |
High Similarity |
NPD1934 |
Approved |
0.8758 |
High Similarity |
NPD2534 |
Approved |
0.8758 |
High Similarity |
NPD2533 |
Approved |
0.8758 |
High Similarity |
NPD2532 |
Approved |
0.8679 |
High Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8679 |
High Similarity |
NPD3882 |
Suspended |
0.8671 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8659 |
High Similarity |
NPD3818 |
Discontinued |
0.8642 |
High Similarity |
NPD6232 |
Discontinued |
0.8609 |
High Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8553 |
High Similarity |
NPD2801 |
Approved |
0.8537 |
High Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8537 |
High Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8537 |
High Similarity |
NPD6166 |
Phase 2 |
0.8485 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8443 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8438 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.8402 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8385 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8383 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8383 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8344 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.8333 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.8333 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8293 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8261 |
Intermediate Similarity |
NPD37 |
Approved |
0.825 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8221 |
Intermediate Similarity |
NPD4966 |
Approved |
0.8221 |
Intermediate Similarity |
NPD4965 |
Approved |
0.8221 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.8217 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8214 |
Intermediate Similarity |
NPD7228 |
Approved |
0.821 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8193 |
Intermediate Similarity |
NPD5711 |
Approved |
0.8193 |
Intermediate Similarity |
NPD5710 |
Approved |
0.8176 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.8176 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8171 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8129 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.8113 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8098 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8081 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.8061 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8024 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7987 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7952 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7949 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7949 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7927 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7919 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7917 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7914 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7904 |
Intermediate Similarity |
NPD919 |
Approved |
0.7898 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7857 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7848 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7841 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.784 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7831 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7829 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7826 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7824 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7821 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7821 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7809 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7799 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7799 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7792 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7792 |
Intermediate Similarity |
NPD943 |
Approved |
0.7771 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7764 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7758 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7746 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7725 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7725 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7722 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7719 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7714 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7714 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7706 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7692 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7688 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7683 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7677 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7677 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7658 |
Intermediate Similarity |
NPD2796 |
Approved |
0.764 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7622 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7622 |
Intermediate Similarity |
NPD920 |
Approved |
0.76 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7582 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7574 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7572 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7548 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7547 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7516 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7514 |
Intermediate Similarity |
NPD5242 |
Approved |
0.75 |
Intermediate Similarity |
NPD5401 |
Approved |
0.75 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7487 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7486 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7469 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7468 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7457 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.743 |
Intermediate Similarity |
NPD8313 |
Approved |
0.743 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7425 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7419 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7403 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7403 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7394 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7394 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7391 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7389 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.738 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7378 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7375 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7375 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7358 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7356 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7354 |
Intermediate Similarity |
NPD5005 |
Approved |
0.7354 |
Intermediate Similarity |
NPD5006 |
Approved |
0.734 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD9268 |
Approved |
0.7329 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7329 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7325 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7316 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7301 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7296 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7289 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7284 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7267 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7267 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7263 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7249 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7249 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7249 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7249 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7249 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7249 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7249 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7247 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7235 |
Intermediate Similarity |
NPD6386 |
Approved |
0.7235 |
Intermediate Similarity |
NPD6385 |
Approved |
0.7234 |
Intermediate Similarity |
NPD4420 |
Approved |
0.7229 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7225 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7219 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7215 |
Intermediate Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.72 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7195 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7195 |
Intermediate Similarity |
NPD2654 |
Approved |
0.719 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7188 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7182 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7178 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7175 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7152 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7152 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7143 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7143 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7125 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7115 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7108 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7097 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7092 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7092 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7089 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7081 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7081 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7081 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7078 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7073 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7073 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.7073 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7073 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.7073 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7047 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7047 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7047 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7043 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7041 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7035 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7035 |
Intermediate Similarity |
NPD7930 |
Approved |
0.7032 |
Intermediate Similarity |
NPD1608 |
Approved |
0.703 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.702 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7019 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7019 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7012 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7012 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7012 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7012 |
Intermediate Similarity |
NPD5408 |
Approved |
0.701 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.701 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7
|
Intermediate Similarity |
NPD411 |
Approved |